National income, self-reported wheezing and asthma diagnosis from the World Health Survey

被引:77
作者
Sembajwe, G. [1 ,2 ,3 ]
Cifuentes, M. [3 ]
Tak, S. W. [3 ]
Kriebel, D. [3 ]
Gore, R. [3 ]
Punnett, L. [3 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA
[3] Univ Massachusetts Lowell, Dept Work Environm, Lowell, MA USA
关键词
Asthma; income inequality; prevalence; wheezing; World Health Survey; HYGIENE HYPOTHESIS; ATOPIC ECZEMA; PREVALENCE; SYMPTOMS; DISEASES;
D O I
10.1183/09031936.00027509
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aims of this study were to quantify and describe the variations in respiratory symptoms and diagnosis prevalence across regions of the world according to national income. In 2002 and 2003, the World Health Organization implemented the World Health Survey (WHS), which used a standardised survey instrument to compile comprehensive baseline information on health and healthcare expenditure. We analysed the WHS data to assess the global patterns of self-reported wheeze and doctor-diagnosed asthma, two commonly reported measures of respiratory health. In total there were 308,218 participants with complete records, from 64 countries. The weighted mean age of the survey population was 43 yrs. Global prevalence of current wheezing symptoms ranged from 2.4% in Vietnam to 24% in Brazil; the prevalence of diagnosed asthma ranged from 1.8% in Vietnam to 32.8% in Australia. Overall, the prevalence of symptoms and diagnosis showed a U-shaped pattern with the largest prevalence reported in low- and high-income countries. The smallest prevalence was consistently found in middle-income countries. These WHS analyses have provided global prevalence estimates of wheeze and doctor-diagnosed asthma using data gathered simultaneously and consistently across six continents. These findings support the need for continued global respiratory illness surveillance for disease prevention, health policy and management.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 51 条
[1]   Are asthma medications and management related to deaths from asthma? [J].
Abramson, MJ ;
Bailey, MJ ;
Couper, FJ ;
Driver, JS ;
Drummer, OH ;
Forbes, AB ;
McNeil, JJ ;
Walters, EH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (01) :12-18
[2]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P665
[3]  
[Anonymous], WORLD FACTB
[4]  
[Anonymous], 2004, ENV BURDEN DIS SERIE
[5]  
[Anonymous], 2006, GLOB STRAT ASTHM MAN
[6]  
Asher I, 2008, NEW ZEAL MED J, V121, P117
[7]   Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema:: ISAAC [J].
Beasley, R ;
Keil, U ;
von Mutius, E ;
Pearce, N ;
Aït-Khaled, N ;
Anabwani, G ;
Anderson, HR ;
Asher, MI ;
Björkstéin, B ;
Burr, ML ;
Clayton, TO ;
Crane, J ;
Ellwood, P ;
Lai, CKW ;
Mallol, J ;
Martinez, FD ;
Mitchell, EA ;
Montefort, S ;
Robertson, CF ;
Shah, JR ;
Sibbald, B ;
Stewart, AW ;
Strachan, DP ;
Weiland, SK ;
Williams, HC .
LANCET, 1998, 351 (9111) :1225-1232
[8]  
Bedirhan-Ustin T, 2001, WHO MULTICOUNTRY SUR
[9]  
Bernstein IL., 1999, Asthma in the workplace, P1
[10]   GINA guidelines on asthma and beyond [J].
Bousquet, J. ;
Clark, T. J. H. ;
Hurd, S. ;
Khaltaev, N. ;
Lenfant, C. ;
O'Byrne, P. ;
Sheffer, A. .
ALLERGY, 2007, 62 (02) :102-112